Skip to main content
. 2013 Nov 6;33(45):17863–17873. doi: 10.1523/JNEUROSCI.2196-13.2013

Figure 3.

Figure 3.

wallenda (DLK) mutation and its downstream factors suppress the NMJ overgrowth in shot. A, Sample confocal images of muscle 4 type Ib NMJs of shotvv/shot3; elav-Gal4/+ (shot), shotvv/shot3; wnd2/+ (shot; wnd/+), shotvv/shot3; wnd2/wnd3 (shot; wnd), shotvv/shot3; elav-Gal4/UAS-bskDN (shot + JnkDN), shotvv/shot3; elav-Gal4/UAS-fbz (shot + FosDN). B, Quantification of the muscle 4 type Ib bouton number in WT, shotvv/shot3 (shot), and shotvv/shot3; wnd2/wnd3 (shot; wnd). C, Quantification of the muscle 4 type Ib bouton number in elav-Gal4/+ (control) and the lower two genotypes in A. **p < 0.001, compared with WT or control. n > 15 for each genotype. Scale bar, 50 μm.